Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Yiyuan Pharmaceutical is a comprehensive pharmaceutical enterprise based in Qingdao, China, specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines. Established in 1993, the company has developed a robust portfolio of products targeting therapeutic areas such as hepatology, respiratory medicine, cardiovascular health, and metabolic disorders. Its flagship products include Compound Glycyrrhizin formulations for liver protection and a wide range of essential generic medications. The company operates large-scale, GMP-certified production facilities and maintains a significant presence in the domestic Chinese healthcare market as a recognized high-tech enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Yiyuan Pharmaceutical.